Trial intelligence / Profile preview

Phase I/II open-label study of ICP-723 in advanced solid tumors

CTR20202270Phase 2Active

Sponsor

Innovent Biologics

Start

Oct 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1